首页 > 最新文献

Taiwanese Journal of Obstetrics & Gynecology最新文献

英文 中文
Impact of niraparib on reducing the platelet count in patients with ovarian cancer 尼拉帕尼对降低卵巢癌患者血小板计数的影响
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.04.024
Mika Mizuno, Mai Nakazono, Mika Fukuda, Shintaro Yanazume, Shinichi Togami, Hiroaki Kobayashi

Objective

Niraparib (NIRA) is a poly(ADP-ribose) polymerase inhibitor used as maintenance therapy for ovarian carcinomas. Thrombocytopenia is a common adverse event associated with NIRA. This study aimed to evaluate the frequency of NIRA-induced thrombocytopenia and the associated risk factors in clinical practice.

Materials and methods

Data from 30 patients who received NIRA as a first-line or recurrent treatment at our institution were retrospectively analyzed to assess reductions in platelet count (PLT).

Results

The median participant age was 59 (range: 39–75) years, and the median weight was 50 (range: 36–80) kg. NIRA was initiated at a median of 4 (range: 3–8) weeks after the last chemotherapy dose. The prevalence of grade ≥3 thrombocytopenia was 23.3 %, dose interruptions occurred in 53.3 % and dose reductions occurred in 40 %. The median follow-up time was 20 (range: 2–166) months after resumption. Due to thrombocytopenia, one patient discontinued treatment 2 weeks after administration (nadir PLT: 1 × 109/L), and 2 others discontinued treatment after resumption. For the non-interruption and interruption groups, the median nadir PLTs were 194 (91–318) and 57 (1–89) × 109/L (p < 0.001), respectively, the median baseline PLTs were 215 vs. 120 × 109/L (p < 0.001), respectively, and the nadir PLTs during prior chemotherapy were 175 vs. 73 × 109/L (p = 0.007), respectively. Lower baseline PLTs were significantly associated with an increased risk of thrombocytopenia (OR 0.793, 95 % CI 0.654–0.964; p = 0.019).

Conclusions

Our real-world data reaffirmed that thrombocytopenia is a significant adverse event that affects the continuation of NIRA and requires careful monitoring. Adjusting the start time to ensure an adequate baseline PLT may help mitigate this risk, but larger-scale studies are needed to validate these findings.
目的:尼拉帕尼(NIRA)是一种用于卵巢癌维持治疗的聚(adp -核糖)聚合酶抑制剂。血小板减少是与NIRA相关的常见不良事件。本研究旨在评估临床实践中nira诱导的血小板减少的频率及其相关危险因素。材料和方法回顾性分析我院接受NIRA作为一线或复发治疗的30例患者的数据,以评估血小板计数(PLT)的降低。结果参与者的中位年龄为59岁(范围:39-75岁),中位体重为50(范围:36-80)kg, NIRA开始于最后一次化疗剂量后的中位4周(范围:3-8周)。≥3级血小板减少发生率为23.3%,剂量中断发生率为53.3%,剂量减少发生率为40%。恢复后中位随访时间为20个月(范围:2-166个月)。1例患者因血小板减少,用药2周后停药(最低PLT: 1 × 109/L), 2例患者恢复治疗后停药。对于非中断组和中断组,平均最低plt分别为194(91-318)和57 (1-89)× 109/L (p < 0.001),平均基线plt分别为215和120 × 109/L (p < 0.001),先前化疗期间的最低plt分别为175和73 × 109/L (p = 0.007)。较低的基线plt与血小板减少的风险增加显著相关(OR 0.793, 95% CI 0.654-0.964; p = 0.019)。结论:我们的真实数据再次证实,血小板减少是影响NIRA持续治疗的重大不良事件,需要仔细监测。调整起始时间以确保足够的基线PLT可能有助于减轻这种风险,但需要更大规模的研究来验证这些发现。
{"title":"Impact of niraparib on reducing the platelet count in patients with ovarian cancer","authors":"Mika Mizuno,&nbsp;Mai Nakazono,&nbsp;Mika Fukuda,&nbsp;Shintaro Yanazume,&nbsp;Shinichi Togami,&nbsp;Hiroaki Kobayashi","doi":"10.1016/j.tjog.2025.04.024","DOIUrl":"10.1016/j.tjog.2025.04.024","url":null,"abstract":"<div><h3>Objective</h3><div>Niraparib (NIRA) is a poly(ADP-ribose) polymerase inhibitor used as maintenance therapy for ovarian carcinomas. Thrombocytopenia is a common adverse event associated with NIRA. This study aimed to evaluate the frequency of NIRA-induced thrombocytopenia and the associated risk factors in clinical practice.</div></div><div><h3>Materials and methods</h3><div>Data from 30 patients who received NIRA as a first-line or recurrent treatment at our institution were retrospectively analyzed to assess reductions in platelet count (PLT).</div></div><div><h3>Results</h3><div>The median participant age was 59 (range: 39–75) years, and the median weight was 50 (range: 36–80) kg. NIRA was initiated at a median of 4 (range: 3–8) weeks after the last chemotherapy dose. The prevalence of grade ≥3 thrombocytopenia was 23.3 %, dose interruptions occurred in 53.3 % and dose reductions occurred in 40 %. The median follow-up time was 20 (range: 2–166) months after resumption. Due to thrombocytopenia, one patient discontinued treatment 2 weeks after administration (nadir PLT: 1 × 10<sup>9</sup>/L), and 2 others discontinued treatment after resumption. For the non-interruption and interruption groups, the median nadir PLTs were 194 (91–318) and 57 (1–89) × 10<sup>9</sup>/L (p &lt; 0.001), respectively, the median baseline PLTs were 215 vs. 120 × 10<sup>9</sup>/L (p &lt; 0.001), respectively, and the nadir PLTs during prior chemotherapy were 175 vs. 73 × 10<sup>9</sup>/L (p = 0.007), respectively. Lower baseline PLTs were significantly associated with an increased risk of thrombocytopenia (OR 0.793, 95 % CI 0.654–0.964; p = 0.019).</div></div><div><h3>Conclusions</h3><div>Our real-world data reaffirmed that thrombocytopenia is a significant adverse event that affects the continuation of NIRA and requires careful monitoring. Adjusting the start time to ensure an adequate baseline PLT may help mitigate this risk, but larger-scale studies are needed to validate these findings.</div></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 75-80"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and diagnostic challenges in a nullipara with spontaneous uterine rupture during vaginal delivery 危险因素和诊断挑战在无孕伴自发性子宫破裂阴道分娩
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.07.029
I-Ning Cheng , Tsung-Hsuan Lai

Objective

To present a rare case of uterine rupture after vaginal delivery under epidural anesthesia in a nulliparous woman without prior uterine surgery.

Case report

A 38-year-old primiparous woman with a history of infertility conceived through in vitro fertilization. At 39 weeks of gestation, she was admitted due to spontaneous premature rupture of membranes. Oxytocin was administered for labor augmentation, and fundal pressure was applied for maternal exhaustion, leading to the delivery of a healthy infant. Secondary laceration of perineum was found but no cervical laceration was detected just after vaginal delivery. Primary repair was performed layers by layers smoothly. Shortly after delivery, the patient developed hypotension, tachycardia, nausea, and poor uterine tone, but without abdominal pain, likely due to epidural anesthesia masking symptoms. Abdominal ultrasound revealed intrauterine clots and some fluid in the cul-de-sac, suggesting uterine rupture. An emergent laparotomy identified a 10 cm posterior uterine laceration, which was successfully repaired.

Conclusion

This case highlights the importance of promptly recognizing atypical or subtle signs of uterine rupture particularly when classical symptoms are masked by epidural anesthesia. Clinicians should maintain a highly suspicion and closely monitor for alternative indicators, such as hemodynamic instability or abnormal fetal heart rate patterns. In addition, fundal pressure should be applied with caution, especially in patients with risk factors for uterine rupture such as myomectomy, to minimize the risk of adverse maternal outcomes.
目的报道一例未做过子宫手术的无产妇女在硬膜外麻醉下阴道分娩后发生子宫破裂的病例。病例报告:一名38岁初产妇,有体外受精不孕史。在怀孕39周时,她因自发性胎膜早破而入院。催产素用于助产,基底压力用于产妇疲劳,导致健康婴儿的出生。会阴部继发撕裂,阴道分娩后未发现宫颈撕裂。初级修复一层一层顺利进行。分娩后不久,患者出现低血压、心动过速、恶心、子宫张力差,但无腹痛,可能是由于硬膜外麻醉掩盖症状所致。腹部超声显示宫内凝块和一些液体,提示子宫破裂。紧急剖腹手术发现子宫后部10厘米撕裂,并成功修复。结论本病例强调了及时识别子宫破裂的非典型或细微体征的重要性,特别是当经典症状被硬膜外麻醉掩盖时。临床医生应保持高度怀疑并密切监测其他指标,如血液动力学不稳定或胎儿心率异常模式。此外,应谨慎使用子宫底压,特别是有子宫破裂危险因素(如子宫肌瘤切除术)的患者,以尽量减少不良产妇结局的风险。
{"title":"Risk factors and diagnostic challenges in a nullipara with spontaneous uterine rupture during vaginal delivery","authors":"I-Ning Cheng ,&nbsp;Tsung-Hsuan Lai","doi":"10.1016/j.tjog.2025.07.029","DOIUrl":"10.1016/j.tjog.2025.07.029","url":null,"abstract":"<div><h3>Objective</h3><div>To present a rare case of uterine rupture after vaginal delivery under epidural anesthesia in a nulliparous woman without prior uterine surgery.</div></div><div><h3>Case report</h3><div>A 38-year-old primiparous woman with a history of infertility conceived through in vitro fertilization. At 39 weeks of gestation, she was admitted due to spontaneous premature rupture of membranes. Oxytocin was administered for labor augmentation, and fundal pressure was applied for maternal exhaustion, leading to the delivery of a healthy infant. Secondary laceration of perineum was found but no cervical laceration was detected just after vaginal delivery. Primary repair was performed layers by layers smoothly. Shortly after delivery, the patient developed hypotension, tachycardia, nausea, and poor uterine tone, but without abdominal pain, likely due to epidural anesthesia masking symptoms. Abdominal ultrasound revealed intrauterine clots and some fluid in the cul-de-sac, suggesting uterine rupture. An emergent laparotomy identified a 10 cm posterior uterine laceration, which was successfully repaired.</div></div><div><h3>Conclusion</h3><div>This case highlights the importance of promptly recognizing atypical or subtle signs of uterine rupture particularly when classical symptoms are masked by epidural anesthesia. Clinicians should maintain a highly suspicion and closely monitor for alternative indicators, such as hemodynamic instability or abnormal fetal heart rate patterns. In addition, fundal pressure should be applied with caution, especially in patients with risk factors for uterine rupture such as myomectomy, to minimize the risk of adverse maternal outcomes.</div></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 119-122"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal and postnatal determinants of clinical outcomes in congenital heart diseases: A 15-year retrospective cohort study 先天性心脏病临床结局的产前和产后决定因素:一项15年回顾性队列研究
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.06.005
Jenn-Jhy Tseng , Shen-Ling Jan , Chia-Jung Hsieh , Li-Ling Lin , Hsien-Wen Peng
<div><h3>Objective</h3><div>Congenital heart diseases (CHDs), the most common congenital anomalies, significantly impact pediatric morbidity and mortality. This 15-year retrospective study investigates prenatal features and postnatal outcomes in CHD cases, focusing on factors influencing surgical intervention, mortality, and long-term care.</div></div><div><h3>Materials and methods</h3><div>We retrospectively reviewed 170 perinatally diagnosed CHD cases at Taichung Veterans General Hospital between January 2008 and October 2023. Diagnosis was primarily based on two-dimensional grayscale and Doppler echocardiography, with speckle tracking echocardiography (STE) employed in several cases. Among these, 119 ongoing pregnancies continued to delivery, 32 ended in termination of pregnancy (TOP) or intrauterine fetal demise (IUFD), and 19 were lost to follow-up. CHDs were categorized using two classification systems based on anatomical, physiological, and locational criteria. Maternal and fetal characteristics and echocardiographic findings were analyzed.</div></div><div><h3>Results</h3><div>Prenatal diagnosis was achieved in 93.5 % of cases, with a median gestational age of 22 weeks at diagnosis. Genetic abnormalities were detected in 3.4 % of cases for karyotypes and 9.3 % for gene dosage changes. CHD subtype distributions varied significantly among outcome groups. In classification-1, left-to-right shunts and arrhythmias predominated in the delivery group, cyanotic CHDs were most common in the TOP/IUFD group, and obstructive lesions/miscellaneous conditions were more frequent in the lost to follow-up group (<em>P</em> = 0.012). In classification-2, right- and left-sided disorders were most frequent in the delivery group, while mixed or unclassified disorders dominated the TOP/IUFD group (<em>P</em> = 0.003). Isolated CHDs accounted for 71.2 % of cases but were significantly less frequent in the TOP/IUFD group (<em>P</em> = 0.001). A higher number of coexistent intracardiac anomalies increased the risk of TOP/IUFD (<em>P</em> < 0.001). Significant group differences were also noted for isolated ventricular septal defect (<em>P</em> = 0.009) and right aortic arch (<em>P</em> = 0.003). Among the 119 deliveries, 24.4 % required early postnatal interventions. Predictive factors included cyanotic CHDs, obstructive lesions, and arrhythmias (<em>P</em> < 0.001). Neonatal mortality was strongly associated with a 5-min Apgar score <7 (adjusted odds ratio [aOR] 6.63, <em>P</em> = 0.037). Coexistent intracardiac anomalies increased the risk of hospital readmission (aOR 1.71, <em>P</em> = 0.034) and post-neonatal surgery (adjusted hazard ratio [aHR] 1.63, <em>P</em> < 0.001). Both STE and conventional echocardiography provided important insights into myocardial function and hemodynamics in severe cases.</div></div><div><h3>Conclusion</h3><div>CHD type, complexity, and coexisting conditions, along with key prenatal and postnatal factors, significantly in
目的生殖道性心脏病(CHDs)是最常见的先天性异常,对儿童的发病率和死亡率有重要影响。这项为期15年的回顾性研究调查了CHD病例的产前特征和产后结局,重点是影响手术干预、死亡率和长期护理的因素。材料与方法回顾性分析2008年1月至2023年10月在台中退伍军人总医院进行围产期诊断的冠心病患者170例。诊断主要基于二维灰度和多普勒超声心动图,在几个病例中使用斑点跟踪超声心动图(STE)。其中119例妊娠持续分娩,32例终止妊娠(TOP)或宫内胎儿死亡(IUFD), 19例失访。根据解剖、生理和定位标准,采用两种分类系统对冠心病进行分类。分析母胎特征及超声心动图表现。结果93.5%的病例获得产前诊断,诊断时中位胎龄为22周。在核型中检测到遗传异常的病例占3.4%,基因剂量变化的病例占9.3%。不同结果组的冠心病亚型分布差异显著。在分类-1中,分娩组以左向右分流和心律失常为主,TOP/IUFD组以紫绀型冠心病最为常见,失访组以梗阻病变/杂项情况更为常见(P = 0.012)。在分类-2中,分娩组以右侧和左侧疾病最常见,而TOP/IUFD组以混合或未分类疾病为主(P = 0.003)。孤立性冠心病占71.2%,但在TOP/IUFD组中发生率明显较低(P = 0.001)。同时存在较多的心内异常增加了TOP/IUFD的风险(P < 0.001)。孤立性室间隔缺损(P = 0.009)和右主动脉弓(P = 0.003)组间差异也有统计学意义。在119例分娩中,24.4%需要产后早期干预。预测因素包括紫绀型冠心病、阻塞性病变和心律失常(P < 0.001)。新生儿死亡率与5分钟Apgar评分<;7密切相关(校正优势比[aOR] 6.63, P = 0.037)。同时存在的心内异常增加了再入院的风险(aOR为1.71,P = 0.034)和新生儿术后手术的风险(校正风险比[aHR]为1.63,P < 0.001)。STE和常规超声心动图对重症患者的心肌功能和血流动力学提供了重要的见解。结论冠心病的类型、复杂性、共存条件以及产前和产后的关键因素对死亡率、手术需求和再入院风险等预后有显著影响。前瞻性研究纳入功能心脏评估是必要的,以进一步改善冠心病的管理。
{"title":"Prenatal and postnatal determinants of clinical outcomes in congenital heart diseases: A 15-year retrospective cohort study","authors":"Jenn-Jhy Tseng ,&nbsp;Shen-Ling Jan ,&nbsp;Chia-Jung Hsieh ,&nbsp;Li-Ling Lin ,&nbsp;Hsien-Wen Peng","doi":"10.1016/j.tjog.2025.06.005","DOIUrl":"10.1016/j.tjog.2025.06.005","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;Congenital heart diseases (CHDs), the most common congenital anomalies, significantly impact pediatric morbidity and mortality. This 15-year retrospective study investigates prenatal features and postnatal outcomes in CHD cases, focusing on factors influencing surgical intervention, mortality, and long-term care.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Materials and methods&lt;/h3&gt;&lt;div&gt;We retrospectively reviewed 170 perinatally diagnosed CHD cases at Taichung Veterans General Hospital between January 2008 and October 2023. Diagnosis was primarily based on two-dimensional grayscale and Doppler echocardiography, with speckle tracking echocardiography (STE) employed in several cases. Among these, 119 ongoing pregnancies continued to delivery, 32 ended in termination of pregnancy (TOP) or intrauterine fetal demise (IUFD), and 19 were lost to follow-up. CHDs were categorized using two classification systems based on anatomical, physiological, and locational criteria. Maternal and fetal characteristics and echocardiographic findings were analyzed.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Prenatal diagnosis was achieved in 93.5 % of cases, with a median gestational age of 22 weeks at diagnosis. Genetic abnormalities were detected in 3.4 % of cases for karyotypes and 9.3 % for gene dosage changes. CHD subtype distributions varied significantly among outcome groups. In classification-1, left-to-right shunts and arrhythmias predominated in the delivery group, cyanotic CHDs were most common in the TOP/IUFD group, and obstructive lesions/miscellaneous conditions were more frequent in the lost to follow-up group (&lt;em&gt;P&lt;/em&gt; = 0.012). In classification-2, right- and left-sided disorders were most frequent in the delivery group, while mixed or unclassified disorders dominated the TOP/IUFD group (&lt;em&gt;P&lt;/em&gt; = 0.003). Isolated CHDs accounted for 71.2 % of cases but were significantly less frequent in the TOP/IUFD group (&lt;em&gt;P&lt;/em&gt; = 0.001). A higher number of coexistent intracardiac anomalies increased the risk of TOP/IUFD (&lt;em&gt;P&lt;/em&gt; &lt; 0.001). Significant group differences were also noted for isolated ventricular septal defect (&lt;em&gt;P&lt;/em&gt; = 0.009) and right aortic arch (&lt;em&gt;P&lt;/em&gt; = 0.003). Among the 119 deliveries, 24.4 % required early postnatal interventions. Predictive factors included cyanotic CHDs, obstructive lesions, and arrhythmias (&lt;em&gt;P&lt;/em&gt; &lt; 0.001). Neonatal mortality was strongly associated with a 5-min Apgar score &lt;7 (adjusted odds ratio [aOR] 6.63, &lt;em&gt;P&lt;/em&gt; = 0.037). Coexistent intracardiac anomalies increased the risk of hospital readmission (aOR 1.71, &lt;em&gt;P&lt;/em&gt; = 0.034) and post-neonatal surgery (adjusted hazard ratio [aHR] 1.63, &lt;em&gt;P&lt;/em&gt; &lt; 0.001). Both STE and conventional echocardiography provided important insights into myocardial function and hemodynamics in severe cases.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;CHD type, complexity, and coexisting conditions, along with key prenatal and postnatal factors, significantly in","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 44-54"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical impact of glandular involvement in high-grade squamous intraepithelial lesions of the cervix 宫颈高级别鳞状上皮内病变中腺体受累的临床影响
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.12.002
Szu-Ting Yang , Che-Wei Chang , Peng-Hui Wang

Objective

The prognostic significance of glandular involvement in high-grade squamous intraepithelial lesions (HSIL) following cervical conization remains unclear. This research aimed to evaluate the clinical impact of glandular involvement on surgical outcomes.

Materials and methods

Between December 2019 and December 2020, 119 patients who underwent cervical conization were retrospectively observed. Patient characteristics, such as human papillomavirus (HPV) status, cytology results, glandular involvement, conization specimen depth and volume, margin status, and recurrence were collected and analyzed.

Results

Glandular involvement was significantly associated with positive endocervical margins (22.0 % vs. 6.5 %, p = 0.017), higher prevalence of preceding HSIL or CIN (cervical intraepithelial neoplasm)2/CIN3 cytology (60.4 % vs. 42.0 %), and increased HPV16 infection among high-risk HPV positive patients (69.2 % vs. 34.8 %, p = 0.050). No significant differences were observed in recurrence rates among patients with HSIL with or without glandular involvement. Multivariable analysis identified that margin status is the only independent predictor of recurrence (positive margin: OR [odds ratio] 26.85, 95 % CI [confidence interval] 2.59–277.86, p = 0.006 or uncertain margins: OR 29.90, 95 % CI 1.09–818.17, p = 0.044).

Conclusion

While glandular involvement in HSIL is associated with positive endocervical margins, abnormal preceding cytology, and higher risk of HPV16 infection, it does not independently predict recurrence following conization. Instead, positive surgical margins are the primary factor of recurrence, highlighting the value of achieving complete excision to optimize patient outcomes.
目的尚不清楚宫颈锥切术后高级别鳞状上皮内病变(HSIL)是否累及腺体对预后的影响。本研究旨在评估腺体受累对手术结果的临床影响。材料与方法对2019年12月至2020年12月间行宫颈锥切术的119例患者进行回顾性观察。收集并分析患者特征,如人乳头瘤病毒(HPV)状态、细胞学结果、腺体受损伤、锥形标本深度和体积、边缘状态和复发。结果腺体受损伤与宫颈内切缘阳性(22.0%比6.5%,p = 0.017)、宫颈上皮内肿瘤(HSIL)或宫颈上皮内肿瘤(CIN)2/CIN3细胞学检查(60.4%比42.0%)、高危HPV阳性患者HPV16感染增加(69.2%比34.8%,p = 0.050)显著相关。有或无腺体受累的HSIL患者的复发率无显著差异。多变量分析表明,切缘状态是复发的唯一独立预测因子(阳性切缘:OR[比值比]26.85,95% CI[置信区间]2.59-277.86,p = 0.006;不确定切缘:OR 29.90, 95% CI 1.09-818.17, p = 0.044)。结论虽然HSIL的腺体累及与宫颈内切缘阳性、前期细胞学异常和HPV16感染的高风险相关,但它不能独立预测锥形切除术后的复发。相反,阳性手术切缘是复发的主要因素,强调了实现完全切除以优化患者预后的价值。
{"title":"Clinical impact of glandular involvement in high-grade squamous intraepithelial lesions of the cervix","authors":"Szu-Ting Yang ,&nbsp;Che-Wei Chang ,&nbsp;Peng-Hui Wang","doi":"10.1016/j.tjog.2025.12.002","DOIUrl":"10.1016/j.tjog.2025.12.002","url":null,"abstract":"<div><h3>Objective</h3><div>The prognostic significance of glandular involvement in high-grade squamous intraepithelial lesions (HSIL) following cervical conization remains unclear. This research aimed to evaluate the clinical impact of glandular involvement on surgical outcomes.</div></div><div><h3>Materials and methods</h3><div>Between December 2019 and December 2020, 119 patients who underwent cervical conization were retrospectively observed. Patient characteristics, such as human papillomavirus (HPV) status, cytology results, glandular involvement, conization specimen depth and volume, margin status, and recurrence were collected and analyzed.</div></div><div><h3>Results</h3><div>Glandular involvement was significantly associated with positive endocervical margins (22.0 % <em>vs</em>. 6.5 %, <em>p</em> = 0.017), higher prevalence of preceding HSIL or CIN (cervical intraepithelial neoplasm)2/CIN3 cytology (60.4 % <em>vs</em>. 42.0 %), and increased HPV16 infection among high-risk HPV positive patients (69.2 % <em>vs</em>. 34.8 %, <em>p</em> = 0.050). No significant differences were observed in recurrence rates among patients with HSIL with or without glandular involvement. Multivariable analysis identified that margin status is the only independent predictor of recurrence (positive margin: OR [odds ratio] 26.85, 95 % CI [confidence interval] 2.59–277.86, <em>p</em> = 0.006 or uncertain margins: OR 29.90, 95 % CI 1.09–818.17, <em>p</em> = 0.044).</div></div><div><h3>Conclusion</h3><div>While glandular involvement in HSIL is associated with positive endocervical margins, abnormal preceding cytology, and higher risk of HPV16 infection, it does not independently predict recurrence following conization. Instead, positive surgical margins are the primary factor of recurrence, highlighting the value of achieving complete excision to optimize patient outcomes.</div></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 64-69"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative management of early-onset cerebral venous thrombosis in pregnancy resulting in full-term delivery: A case report 妊娠期早发性脑静脉血栓形成致足月分娩的保守治疗1例
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.09.022
Xiaoqian Pan , Xiaoli Zhang , Rui Qin , Heyun Ruan

Objective

Cerebral venous thrombosis is a rare disease with a high mortality rate. Pregnancy can increase the risk of intracranial venous sinus thrombosis formation, and this condition in turn elevates the maternal mortality rate. Therefore, early diagnosis and appropriate treatment of intracranial venous sinus thrombosis during pregnancy are crucial for the prognosis of pregnant women.

Case Report

We present a case of 30-year-old woman who had a spontaneous conception, thrombophilia occurring in the early stages of pregnancy, which was further aggravated by cerebral venous thrombosis. However, with appropriate medical intervention, a successful full-term delivery occurred.

Conclusion

The management of cerebral venous thrombosis during pregnancy is of great importance. When the patient's condition permits, conservative treatment can be adopted, leading to a favorable prognosis for both the mother and the fetus.
目的脑静脉血栓形成是一种死亡率高的罕见疾病。妊娠可增加颅内静脉窦血栓形成的风险,而这种情况反过来又提高了孕产妇死亡率。因此,妊娠期颅内静脉窦血栓形成的早期诊断和适当治疗对孕妇的预后至关重要。病例报告:我们报告一例30岁女性自然受孕,在妊娠早期发生血栓性疾病,并因脑静脉血栓形成而进一步加重。然而,通过适当的医疗干预,成功的足月分娩发生了。结论妊娠期脑静脉血栓的处理十分重要。在患者条件允许的情况下,可采取保守治疗,母子预后均良好。
{"title":"Conservative management of early-onset cerebral venous thrombosis in pregnancy resulting in full-term delivery: A case report","authors":"Xiaoqian Pan ,&nbsp;Xiaoli Zhang ,&nbsp;Rui Qin ,&nbsp;Heyun Ruan","doi":"10.1016/j.tjog.2025.09.022","DOIUrl":"10.1016/j.tjog.2025.09.022","url":null,"abstract":"<div><h3>Objective</h3><div>Cerebral venous thrombosis is a rare disease with a high mortality rate. Pregnancy can increase the risk of intracranial venous sinus thrombosis formation, and this condition in turn elevates the maternal mortality rate. Therefore, early diagnosis and appropriate treatment of intracranial venous sinus thrombosis during pregnancy are crucial for the prognosis of pregnant women.</div></div><div><h3>Case Report</h3><div>We present a case of 30-year-old woman who had a spontaneous conception, thrombophilia occurring in the early stages of pregnancy, which was further aggravated by cerebral venous thrombosis. However, with appropriate medical intervention, a successful full-term delivery occurred.</div></div><div><h3>Conclusion</h3><div>The management of cerebral venous thrombosis during pregnancy is of great importance. When the patient's condition permits, conservative treatment can be adopted, leading to a favorable prognosis for both the mother and the fetus.</div></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 99-102"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal diagnosis of a 2.61-Mb de novo 22q11.21 microduplication encompassing TBX1 in a pregnancy associated with no apparently phenotypic abnormality in the fetus 产前诊断胎儿中包含TBX1的2.61 mb新生22q11.21微重复,胎儿无明显表型异常
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.11.007
Chih-Ping Chen
{"title":"Prenatal diagnosis of a 2.61-Mb de novo 22q11.21 microduplication encompassing TBX1 in a pregnancy associated with no apparently phenotypic abnormality in the fetus","authors":"Chih-Ping Chen","doi":"10.1016/j.tjog.2025.11.007","DOIUrl":"10.1016/j.tjog.2025.11.007","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 134-135"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of mismatch repair genes deficiency on survival outcomes and establishment of a novel prognostic prediction model for stage I-II endometrial carcinoma 错配修复基因缺失对I-II期子宫内膜癌生存结果的影响及新型预后预测模型的建立
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.08.004
Wenhui Wang , Zihan Yan , Yuanyuan Chen , Kang Ren , Xiaorong Hou , Ke Hu , Fuquan Zhang

Objective

Pathological characteristics and MMR status can be determined from microscopic indicators and immunohistochemical (IHC) staining of surgical specimens, and these approaches are more cost-effective and convenient than genome profiling tests. We aimed to evaluate the impact of MMR deficiency on survival outcomes and build a new prognostic model for early-stage endometrial carcinoma (EC) patients.

Materials and methods

Patients with stage I to II EC who underwent hysterectomy followed by adjuvant radiotherapy from Oct. 2017 to Dec. 2020 at our institution were retrospectively reviewed. Tumor MMR status was routinely tested by IHC. According to MMR status, they were classified into intact MMR (MMRp) group and defective MMR (MMRd) group.

Results

Patients were classified into MMRp group (n = 207) and MMRd group (n = 69). Compared with those in the MMRp group, patients in the MMRd group were more likely to have high-grade disease, LVSI, and high-intermediate risk (HIR)-to-high risk (HR) classifications. The 3-year CSS, DFS, and DMFS rates were significantly lower in the MMRd group. When patients were stratified by risk group, DFS and DMFS were significantly worse among MMRd patients in the HIR-to-HR group. Regarding failure patterns, MMRd patients were more likely to experience distant failure. Among 276 patients, multivariate Cox analysis revealed that ER or PR status, myometrial invasion (MI), MMR status, and LVSI were independent prognostic factors for DFS, whereas ER or PR status, MMR status, and MI were significant predictors of DMFS. A prediction model combining the MMR status and the significant prognostic predictors mentioned above in the multivariate analysis was built through nomogram models.

Conclusion

Among early-stage EC patients, MMRd group had poorer survivals. Combination of MMR status and other clinicopathological factors could establish a new prognostic model. Prospective studies with full molecular sequencing to determine the prognostic significance of MMR status are needed.
目的通过手术标本的显微指标和免疫组化(IHC)染色来确定病理特征和MMR状态,这些方法比基因组谱检测更经济、更方便。我们旨在评估MMR缺乏对早期子宫内膜癌(EC)患者生存结果的影响,并建立一个新的预后模型。材料与方法回顾性分析我院2017年10月至2020年12月行子宫切除术后辅助放疗的I ~ II期EC患者。常规免疫组化检测肿瘤MMR状态。根据MMR状态分为完整MMR (MMRp)组和缺陷MMR (MMRd)组。结果患者分为MMRp组(207例)和MMRd组(69例)。与MMRp组相比,MMRd组患者更有可能出现高级别疾病、LVSI和高-中危(HIR)-高危(HR)分类。MMRd组的3年CSS、DFS和DMFS率显著降低。当患者按风险组分层时,hir - hr组MMRd患者的DFS和DMFS明显更差。关于失败模式,MMRd患者更有可能经历远端失败。在276例患者中,多因素Cox分析显示,ER或PR状态、肌层浸润(MI)、MMR状态和LVSI是DFS的独立预后因素,而ER或PR状态、MMR状态和MI是DMFS的重要预测因素。通过nomogram模型,将多变量分析中MMR状态与上述显著预后预测因子相结合,建立预测模型。结论在早期EC患者中,MMRd组生存率较低。MMR状态与其他临床病理因素的结合可建立新的预后模型。需要进行全分子测序的前瞻性研究,以确定MMR状态的预后意义。
{"title":"Impact of mismatch repair genes deficiency on survival outcomes and establishment of a novel prognostic prediction model for stage I-II endometrial carcinoma","authors":"Wenhui Wang ,&nbsp;Zihan Yan ,&nbsp;Yuanyuan Chen ,&nbsp;Kang Ren ,&nbsp;Xiaorong Hou ,&nbsp;Ke Hu ,&nbsp;Fuquan Zhang","doi":"10.1016/j.tjog.2025.08.004","DOIUrl":"10.1016/j.tjog.2025.08.004","url":null,"abstract":"<div><h3>Objective</h3><div>Pathological characteristics and MMR status can be determined from microscopic indicators and immunohistochemical (IHC) staining of surgical specimens, and these approaches are more cost-effective and convenient than genome profiling tests. We aimed to evaluate the impact of MMR deficiency on survival outcomes and build a new prognostic model for early-stage endometrial carcinoma (EC) patients.</div></div><div><h3>Materials and methods</h3><div>Patients with stage I to II EC who underwent hysterectomy followed by adjuvant radiotherapy from Oct. 2017 to Dec. 2020 at our institution were retrospectively reviewed. Tumor MMR status was routinely tested by IHC. According to MMR status, they were classified into intact MMR (MMRp) group and defective MMR (MMRd) group.</div></div><div><h3>Results</h3><div>Patients were classified into MMRp group (n = 207) and MMRd group (n = 69). Compared with those in the MMRp group, patients in the MMRd group were more likely to have high-grade disease, LVSI, and high-intermediate risk (HIR)-to-high risk (HR) classifications. The 3-year CSS, DFS, and DMFS rates were significantly lower in the MMRd group. When patients were stratified by risk group, DFS and DMFS were significantly worse among MMRd patients in the HIR-to-HR group. Regarding failure patterns, MMRd patients were more likely to experience distant failure. Among 276 patients, multivariate Cox analysis revealed that ER or PR status, myometrial invasion (MI), MMR status, and LVSI were independent prognostic factors for DFS, whereas ER or PR status, MMR status, and MI were significant predictors of DMFS. A prediction model combining the MMR status and the significant prognostic predictors mentioned above in the multivariate analysis was built through nomogram models.</div></div><div><h3>Conclusion</h3><div>Among early-stage EC patients, MMRd group had poorer survivals. Combination of MMR status and other clinicopathological factors could establish a new prognostic model. Prospective studies with full molecular sequencing to determine the prognostic significance of MMR status are needed.</div></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 81-88"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-level mosaicism for 45,X in 45,X/46,XX at amniocentesis associated with postnatal progressive decrease of the 45,X cell line and a favorable fetal outcome in a twin pregnancy 在双胎妊娠中,45、X、X/46、XX在羊膜穿刺术中的高水平嵌合与出生后45、X细胞系的进行性减少和有利的胎儿结局相关
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.11.012
Chih-Ping Chen
{"title":"High-level mosaicism for 45,X in 45,X/46,XX at amniocentesis associated with postnatal progressive decrease of the 45,X cell line and a favorable fetal outcome in a twin pregnancy","authors":"Chih-Ping Chen","doi":"10.1016/j.tjog.2025.11.012","DOIUrl":"10.1016/j.tjog.2025.11.012","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 149-150"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mosaic 17q24.3q25.3 duplication at amniocentesis in a pregnancy associated with a favorable fetal outcome in a male fetus 妊娠期羊膜穿刺术中嵌合17q24.3q25.3重复与男性胎儿的良好胎儿结局相关
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.11.018
Chih-Ping Chen
{"title":"Mosaic 17q24.3q25.3 duplication at amniocentesis in a pregnancy associated with a favorable fetal outcome in a male fetus","authors":"Chih-Ping Chen","doi":"10.1016/j.tjog.2025.11.018","DOIUrl":"10.1016/j.tjog.2025.11.018","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 164-166"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular cytogenetic characterization of a de novo small supernumerary marker chromosome detected by amniocentesis and derived from the acrocentric chromosome 14/22 羊膜穿刺术检测到一条源自14/22外中心染色体的新生小多余标记染色体的分子细胞遗传学特征
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.tjog.2025.11.009
Chih-Ping Chen , Ming Chen , Gwo-Chin Ma , Shun-Ping Chang , Wayseen Wang
{"title":"Molecular cytogenetic characterization of a de novo small supernumerary marker chromosome detected by amniocentesis and derived from the acrocentric chromosome 14/22","authors":"Chih-Ping Chen ,&nbsp;Ming Chen ,&nbsp;Gwo-Chin Ma ,&nbsp;Shun-Ping Chang ,&nbsp;Wayseen Wang","doi":"10.1016/j.tjog.2025.11.009","DOIUrl":"10.1016/j.tjog.2025.11.009","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"65 1","pages":"Pages 140-142"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Taiwanese Journal of Obstetrics & Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1